Overview

A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Status:
Unknown status

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

A phase IIa study to evaluate the pharmacokinetic and efficacy of amonafide L-malate (AS1413) in combination with cytarabine in treating patients with acute myeloid leukemia (AML)

Phase:

Phase 2

Details

Lead Sponsor:

Antisoma Research

Treatments:

Amonafide
Cytarabine